Court Backs Drug Cos. In Suicide Cases

Law360 (April 9, 2008, 12:00 AM EDT) -- The U.S. Court of Appeals for the Third Circuit has ruled that federal guidelines on drug warning labels trump state law in a case involving two people who committed suicide while taking antidepressants.

The families of the deceased sued GlaxoSmithKline and Pfizer under state failure-to-warn laws. Warning labels on Paxil and Zoloft did not include strong enough warnings about the risk of suicide and worsening depression, they said.

In a 2-1 decision, the appeals court rejected that argument Tuesday. It ruled that the drugmakers could not...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.